Johnson & Johnson to Participate in the Cantor Virtual Global Healthcare Conference
Johnson & Johnson (NYSE: JNJ) will participate in the Cantor Virtual Global Healthcare Conference on September 28, 2021. Mathai Mammen, Global Head of Research & Development at Janssen, and Scott White, Company Group Chairman of NA Pharmaceuticals, will represent the company in a session at 10:00 a.m. ET.
The live webcast can be accessed via the Johnson & Johnson website, with a replay available 48 hours post-event.
- None.
- None.
NEW BRUNSWICK, N.J., Aug. 26, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Cantor Virtual Global Healthcare Conference on Tuesday, September 28th. Mathai Mammen, Global Head, Research & Development Janssen Research Development and Scott White, Company Group Chairman NA Pharmaceuticals will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately 48-hrs after the live webcast.
View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-cantor-virtual-global-healthcare-conference-301363618.html
SOURCE Johnson & Johnson
FAQ
When is Johnson & Johnson participating in the Cantor Virtual Global Healthcare Conference?
Who will represent Johnson & Johnson at the Cantor Conference?
What time is Johnson & Johnson's session at the Cantor Conference?
Where can I watch the Johnson & Johnson Cantor Conference webcast?
Will there be a replay of the Johnson & Johnson webcast?
